Contact: info@alspinc.com

About Us


American Life Science Pharmaceuticals is led by a dedicated team of experienced executives, scientists and thought leaders that have extensive business and clinical experience in drug development.

Neurodegenerative Conditions increase with advancing age...
 
1 in 3 individuals over 80 risk Alzheimer's disease 
1 in 100 individuals over 85 risk Parkinson's disease 
1 in 10,000 risk Huntington's disease
 
...TBI increases risk of dementia
by as much as two-fold
 




ALSP Inc. is led by a dedicated team of experienced executives, scientists and thought leaders that have extensive business and clinical experience in drug development.

ALSP Inc. Management Team

 

 

Michael D. Pierschbacher, Ph. D.

President and Chief Executive Officer

Steven Jacobsen, Ph.D. 

Sr. Vice President and Chief Scientific Officer

 

Gregory Hook, Ph.D., J.D.

Co-Founder, Vice President Research, and Corporate Counsel

Robert J. Ternansky, Ph.D.

Vice President, Medicinal Chemistry

 

Gregory P. Einhorn, Ph.D., J.D.

Vice President, Intellectual Property


< Back

 

Michael D. Pierschbacher, Ph.D.

President and Chief Executive Officer


Prior to joining ALSP Inc. as President and Chief Executive Officer, Dr. Pierschbacher was Senior Vice President at Integra LifeSciences Corporation, a Princeton, New Jersey-based medical device company and was appointed Director of the Corporate Research Center, located in San Diego, California in 1998.

 

Dr. Pierschbacher was a founder of Telios Pharmaceuticals, Inc. and served as Senior Vice President and Scientific Director from June 1987 until it was acquired by Integra in 1995. He was a co-discoverer, along with Dr. Erkki Ruoslahti, who was awarded the Japan Prize for work in this area, of the Arg-Gly-Asp (RGD) cell binding peptide sequence and the family of integrin cell-surface receptors that recognize that sequence, the technology on which Telios was based.

 

Before joining Telios as a full-time employee in October 1988, he was a staff scientist at the La Jolla Cancer Research Foundation, now called The Sanford-Burnham Medical Research Institute, and remained on staff there in adjunct capacity until the end of 1995.

 

Dr. Pierschbacher holds a Ph.D. in Biochemistry from University of Missouri-Columbia.